The Danish Myeloma Study Group (DMSG) was established as an independent Danish multidisciplinary cancer group in 2005, under The Danish Society of Hematology.

The primary focus of DMSG is to secure quality, development and national consensus within diagnosing and treatment of myeloma patients in Denmark.